These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1760593)

  • 1. Disopyramide analysis using REMEDi: comparison with EMIT and conventional high performance liquid chromatographic methods.
    Patel V; McCarthy PT; Flanagan RJ
    Biomed Chromatogr; 1991 Nov; 5(6):269-72. PubMed ID: 1760593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the REMEDi drug profiling system.
    Demedts P; Wauters A; Franck F; Neels H
    Eur J Clin Chem Clin Biochem; 1994 May; 32(5):409-17. PubMed ID: 8086525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a solid/liquid extraction method for analysis of toxic drugs in serum using an automated liquid chromatograph: the Remedi.
    Guitton J; Durand D; Bouillod N; Manchon M
    Ann Biol Clin (Paris); 1994; 52(2):111-5. PubMed ID: 7802337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of caffeine: comparison of the manual enzyme multiplied immunoassay (EMIT), automated EMIT, and high-performance liquid chromatography procedures.
    Miceli JN; Aravind MK; Ferrell WJ
    Ther Drug Monit; 1984; 6(3):344-7. PubMed ID: 6390796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatographic analysis of disopyramide and its mono-N-dealkylated metabolite.
    Lima JJ
    Clin Chem; 1979 Mar; 25(3):405-8. PubMed ID: 262180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative high-performance liquid-chromatographic method for determining disopyramide (Norpace) in serum.
    Broussard LA; Frings CS
    Clin Toxicol; 1979; 14(5):579-86. PubMed ID: 498727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-pressure liquid chromatographic analysis of drugs in biological fluids. III. Analysis of disopyramide and its mono-N-dealkylated metabolite in plasma and urine.
    Meffin PJ; Harpat SR; Harrison DC
    J Chromatogr; 1977 Feb; 132(3):503-10. PubMed ID: 885947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
    Valentine JL; Middleton R; Sparks C
    J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of REMEDi HS in emergency toxicology for a rapid estimate of drug concentrations in urine, serum, and gastric samples.
    Ohtsuji M; Lai JS; Binder SR; Kondo T; Takayasu T; Ohshima T
    J Forensic Sci; 1996 Sep; 41(5):881-6. PubMed ID: 8789851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of the Remedi chromatography automate for the analytic diagnosis of drug poisoning].
    Manchon M; Mialon A; Berny C; Baltassat P
    Ann Biol Clin (Paris); 1997; 55(3):223-8. PubMed ID: 9238424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a high pressure liquid chromatographic analysis and an enzyme immunoassay technique for quantitation of disopyramide in serum or plasma.
    Bryson SM; Betts A; Summer DJ; Whiting B
    J Clin Hosp Pharm; 1982 Jun; 7(2):119-26. PubMed ID: 7050181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in human plasma by capillary electrophoresis.
    Jabor VA; Lanchote VL; Bonato PL
    Electrophoresis; 2001 Apr; 22(7):1406-12. PubMed ID: 11379964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of identification methods of compounds from the opium alkaloids groups on Remedi HS instrument with immunoassay methods].
    Wilimowska J
    Przegl Lek; 2000; 57(10):568-71. PubMed ID: 11199890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine.
    Hutsell TC; Stachelski SJ
    J Chromatogr; 1975 Mar; 106(1):151-8. PubMed ID: 1150784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in chromatography for clinical drug analysis: supercritical fluid chromatography, capillary electrophoresis, and selected high-performance liquid chromatography techniques.
    Wong SH
    Ther Drug Monit; 1993 Dec; 15(6):576-80. PubMed ID: 8122297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic determination of creatinine.
    Ekelund S; Påby P
    Scand J Clin Lab Invest; 1991 Feb; 51(1):67-71. PubMed ID: 2020832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of benzodiazepines in clinical serum samples: comparative evaluation of REMEDi system, aca analyzer, and conventional HPLC performance.
    Chang TL; Chen KW; Lee YD; Fan K
    J Clin Lab Anal; 1999; 13(3):106-11. PubMed ID: 10323474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry.
    Lee HK; Ho CS; Iu YP; Lai PS; Shek CC; Lo YC; Klinke HB; Wood M
    Anal Chim Acta; 2009 Sep; 649(1):80-90. PubMed ID: 19664466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinidine assays: enzyme immunoassay versus high performance liquid chromatography.
    Lehmann CR; Boran KJ; Pierson WP; Melikian AP; Wright GJ
    Ther Drug Monit; 1986; 8(3):336-9. PubMed ID: 3529517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.